How this ETF's holdings score on the six lenses, weighted by holding weight. A transparency roll-up of the stock atom — descriptive, not a forecast of outperformance.
Glass box
Click a lens to expand its holdings, ranked by contribution (weight × decile); each name links to its own evidence. Descriptive, not a forecast.
Trend
AXISHCETF daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
AXISHCETF ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
| Symbol | Sector | Weight | Tch | Fnd | Cat | Flw | Val | Lead | RS 3M |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | Pharma | 18.31% | 7 | 8 | 7 | 8 | 5 | — | +1.5% |
| DIVISLAB | Pharma | 8.90% | 9 | 8 | 1 | 4 | 1 | — | +38.4% |
| APOLLOHOSP | Healthcare | 8.01% | 9 | 5 | 5 | 2 | 2 | — | +0.4% |
| CIPLA | Pharma | 7.20% | 4 | 3 | 6 | 4 | 7 | — | -3.9% |
| MAXHEALTH | Healthcare | 7.10% | 1 | 9 | 6 | 5 | 6 | — | -6.0% |
| TORNTPHARM | Pharma | 6.53% | 7 | 8 | 5 | 4 | 1 | — | +7.0% |
| LAURUSLABS | Pharma | 6.14% | 9 | 9 | 3 | 3 | 1 | — | +29.2% |
| DRREDDY | Pharma | 6.08% | 2 | 2 | 6 | 10 | 9 | — | -14.7% |
| LUPIN | Pharma | 5.09% | 3 | 10 | 10 | 7 | 9 | — | -11.1% |
| FORTIS | Healthcare | 4.28% | 4 | 8 | 5 | 5 | 6 | — | -12.4% |
| AUROPHARMA | Pharma | 3.80% | 8 | 3 | 10 | 6 | 7 | — | +9.9% |
| ALKEM | Pharma | 2.92% | 3 | 8 | 7 | 6 | 8 | — | -6.6% |
| GLENMARK | Pharma | 2.92% | 10 | 9 | 9 | 4 | 3 | — | +8.2% |
| BIOCON | Pharma | 2.64% | 4 | 1 | 10 | 2 | 7 | — | -8.8% |
| ZYDUSLIFE | Pharma | 2.45% | 9 | 10 | 10 | 2 | 8 | — | +1.9% |
| MANKIND | Pharma | 2.43% | 4 | 8 | 9 | 3 | 5 | — | -6.1% |
| IPCALAB | Pharma | 2.11% | 9 | 5 | 1 | 3 | 4 | — | +14.3% |
| ABBOTINDIA | Pharma | 1.25% | 3 | 9 | — | 6 | 8 | — | -3.8% |
| PPLPHARMA | Pharma | 1.06% | 10 | 1 | 5 | 9 | 5 | Leader | +28.4% |
| SYNGENE | Healthcare | 0.64% | 1 | 2 | 6 | 7 | 7 | — | -17.8% |
Native from atlas_foundation — the lens journal looked through de_etf_holdings; identity from Morningstar (de_mf_master). ← Back to ETFs